When you need a medical answer

Tackling the diagnostic challenge with whole exome sequencing

With CentoXome®, CENTOGENE offers a cost-effective, one-step solution by sequencing an individual's entire genomic coding region.

  1. Whole Exome Sequencing

Whole exome sequencing

Most of the disease-causing mutations that science has been able to identify so far are located within the exons. Whereas most genetic tests focus on a single gene or on a set number of predetermined genes, a whole exome sequencing test examines thousands of genes simultaneously.

For certain patients the combination of symptoms does not allow the clinician to pinpoint a potential diagnosis. Therefore ordering genetic testing becomes complex and a stepwise diagnostic strategy which often significantly increases costs. Furthermore, a delayed diagnosis may have a dramatic impact on the patient’s quality of life. CentoXome®, CENTOGENE’s whole exome sequencing service, offers a fast and cost-effective one-step solution which involves sequencing the entire coding region. 

Whole exome sequencing provides a comprehensive outlook on coding genetic variation to a degree that has never been possible before, surpassing traditional methods for the study of common, rare and novel genetic variations, such as SNP arrays or single locus resequencing studies.

Why choose CENTOGENE?

Highest sequencing quality (coverage, numbers of runs, etc.)

Bioinformatic analysis, including variant annotation and phenotypic information

Extensive validation of all results

World-class medical reports interpreted by expert human geneticists

Whole exome sequencing at CENTOGENE – CentoXome®

CentoXome® Platinum

Some cases require urgent attention (e.g. prenatal testing) and a superior coverage depth. The CentoXome® Platinum service includes additionally to the CentoXome® Gold features these unique quality characteristics:

  • Express turnaround time (TAT) of less than 15 days

Order CentoXome® Platinum

CentoXome® Gold

Making genetic testing of the highest quality universally available is a top priority.

CentoXome® Gold – whole exome TRIO testing:

  • Validation of the sequencing results
  • In-depth medical report
  • Extended clinical report

Order CentoXome® Gold

Tailored services to your patient's needs

FeaturesCentoXome® PlatinumCentoXome® Gold
TATLess than 15 daysLess than 30 days
Coverage depthCoverage of 100x, with approx. 97-98% of the targeted bases covered >10x.
Prenatal testing

Detailed information on all available
CentoXome® packages

When is WES required?

For several patients the combination of symptoms does not allow suspecting specific single genetic causes with a high certainty. Therefore medical answers are likely to be obtained only through sequencing the complete coding region, i.e. the whole exome.

We particularly recommend indicating whole exome sequencing for patients with:

  • Epilepsy
  • Neurodevelopmental disorders
  • Bone diseases
  • Metabolic disorders
  • Cardiomyopathy
  • Short stature
  • Complex dysmorphism
  • SCID
  • Immunological disorders
  • Dementia
  • Autism
  • Blindness

  • Whole exome sequencing - Patient information


Clinical anamnesis and reporting

For whole exome sequencing it is mandatory to obtain specific and detailed clinical information.
Withholding any clinical or medical information – including your patient’s family history – may impact test results and their interpretation.

In genetic testing, the interpretation of a given result typically depends on the inheritance mode (autosomal dominant, autosomal recessive, x-linked, etc.).

Therefore we always need a detailed family history and pedigree to interpret the data correctly.

Our mutation database (CentoMD®) includes the systematic documentation of over 100,000 mutations and variants of unknown significance (VUS) coming from a worldwide cohort of patients. With CentoMD® we are offering a tool for the transfer of the findings into a comprehensive medical report, empowering clinical interpretation.

This improves significantly the quality and consistency of the diagnosis, impacting your patients´ treatment options.

CENTOGENE adheres to the “ACMG Recommendations for Reporting of Incidental Findings” and will not report on findings not directly related to the cause of a disease and not listed in the ACMG guidelines (download here).

  • CentoXome® Gold Trio plus diagnostic sample report

  • CentoXome® Gold Trio diagnostic sample report

  • CentoXome® Gold Solo diagnostic sample report


CentoXome® case studies

Detailed insights can be found in our cases studies and scientific publications.

Latest articles about whole exome sequencing

CentoCard® – simplify your logistics

Sending patients´ samples as easy as mailing a postcard.

Order now

CentoPortal® – online ordering portal

Manage your genetic testing online supported by CentoCard®.

Read more

Get in touch with our Department of Medical Quality and Counseling

Please call or send us an email with any questions and benefit from our medical consultation services, available both before and after testing.

+49 - 381 - 203 - 652 - 222 

Mon. – Fri. 7 a.m.– 8 p.m. CET • Sat. – Sun. 9 a.m – 5 p.m. CET

Contact us

Medical Expert Team Member
Medical Expert Team Member
Medical Expert Team Member
Medical Expert Team Member
Medical Expert Team Member
Medical Expert Team Member
Medical Expert Team Member
Medical Expert Team Member

Our consultation service is available in the following languages:

English, German, French, Italian, Spanish, Dutch, Russian, Arabic, Turkish, Serbian, Macedonian and Bulgarian